Core Scientific, Inc.
CORZ
$8.63
$0.627.74%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -1.32B | -1.25B | -831.04M | -35.41M | -246.49M |
Total Depreciation and Amortization | 120.12M | 121.91M | 116.63M | 105.92M | 96.45M |
Total Amortization of Deferred Charges | 3.76M | 3.11M | 1.88M | 1.41M | 752.00K |
Total Other Non-Cash Items | 1.26B | 1.01B | 579.10M | -198.45M | 47.42M |
Change in Net Operating Assets | -27.64M | 160.40M | 183.95M | 193.87M | 166.98M |
Cash from Operations | 42.90M | 50.79M | 50.52M | 67.35M | 65.11M |
Capital Expenditure | -94.96M | -77.85M | -49.42M | -46.52M | -16.16M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | 14.00M | 14.00M | 14.00M | 14.00M |
Other Investing Activities | -231.00K | -184.00K | -244.00K | -579.00K | -833.00K |
Cash from Investing | -95.19M | -64.03M | -35.66M | -33.10M | -3.00M |
Total Debt Issued | 1.06B | 447.61M | -- | -- | -- |
Total Debt Repaid | -310.86M | -315.51M | -66.49M | -60.88M | -44.65M |
Issuance of Common Stock | 59.89M | 56.92M | 55.38M | 55.01M | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 12.77M | 14.08M | 16.61M | 16.61M | -- |
Cash from Financing | 819.57M | 203.10M | 5.49M | 10.74M | -44.65M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 767.27M | 189.86M | 20.35M | 44.98M | 17.47M |